Vascular BioSciences Announces Publication of “Assessment of microRNA and gene dysregulaton in pulmonary hypertension by endoarterial biopsy” in the Current Issue of Pulmonary Circulation Goleta, CA., May 19, 2017 – Vascular BioSciences announces publication of “Assessment of mi

Vascular BioSciences announces publication of “Challenges in the development of chronic pulmonary hypertension models in large animals” in the Current Issue of Pulmonary Circulation Goleta, CA., February 1, 2017 – Vascular BioSciences announces publication of “Challenges in the

Vascular BioSciences’ Sepsis Research Wins Award at the 46th Annual Critical Care Congress of the Society of Critical Care Medicine Hydrocortisone Therapy with CAR Peptide Protects the Injured Endothelial Glycocalyx in Sepsis. Honolulu, HI, January 22, 2017 – On January 22

Vascular BioSciences congratulates VP of Communications, Dr. Susana Peinado, Ph.D., on being awarded her Doctorate from UCSB School of Communication Goleta, Ca, June 7, 2016 — Vascular BioSciences announced today that Dr. Susana Peinado, Ph.D., Vice President of Communications at Vasc

Vascular BioSciences to Make Six Presentations at the American Thoracic Society in San Francisco from May 15 – May 18 Vascular BioSciences to present the full scope of its research efforts at this year’s ATS International ConferenceGoleta, CA, May 12, 2016 – Vascular BioSciences annou

Vascular BioSciences Named the 2015 Winner of the Buzz of Bio “Pipelines of Promise” Competition Goleta, CA, May 21, 2015 – On April 30, 2015, the Biotech International Organization (BIO) announced Vascular BioSciences (VBS) as the winner of its Buzz of BIO competition in the “P

The American Journal of Pathology Highlights “CAR Selectively Enhances Drug Efficacy in PAH” as a Featured Article in the February 2014 Issue Goleta, CA, February 5, 2014 – The American Journal of Pathology announced in a press release that a peer-reviewed scientific article about Vas

Vascular BioSciences Announces Online Publication of Scientific Article Describing First Orally Available Disease Homing Peptide That Can Selectively Enhance the Effects of Co-Administered Drugs Goleta, CA, January 6, 2014 – Vascular BioSciences announces the e-publication of “A

Vascular BioSciences Awarded $1.2 Million Contract from the NHLBI’s Vascular Interventions/Innovations and Therapeutic Advances (VITA) Program to Develop CAR Peptide Therapeutic Adjuvant for PAH Targeted Therapy Durham, NC – Vascular BioSciences (VBS) announced the award of a $1.2 mil

Vascular BioSciences announces publication of “Vascular Histomolecular Analysis By Sequential Endoarterial Biopsy in a Shunt Model of Pulmonary Hypertension” in the Current Issue of Pulmonary Circulation Goleta, CA., April 10, 2013 – Vascular BioSciences announces the publication of “